Emilsé Bermejo

530 total citations
23 papers, 214 citations indexed

About

Emilsé Bermejo is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Emilsé Bermejo has authored 23 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Genetics. Recurrent topics in Emilsé Bermejo's work include Platelet Disorders and Treatments (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Emilsé Bermejo is often cited by papers focused on Platelet Disorders and Treatments (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Emilsé Bermejo collaborates with scholars based in Argentina, United States and France. Emilsé Bermejo's co-authors include M.A. Lazzari, Ruth E. Rosenstein, Sara E. Bari, Daniel A. Sáenz, Susana Meschengieser, Analía Sánchez‐Luceros, Paquita Nurden, Alan T. Nurden, Graciela Dran and Adriana Inés Woods and has published in prestigious journals such as Kidney International, Thrombosis and Haemostasis and Thrombosis Research.

In The Last Decade

Emilsé Bermejo

20 papers receiving 213 citations

Peers

Emilsé Bermejo
Chittibabu Vatte Saudi Arabia
Kristine M. Morin United States
Kanwaldeep Mallhi United States
Chittibabu Vatte Saudi Arabia
Emilsé Bermejo
Citations per year, relative to Emilsé Bermejo Emilsé Bermejo (= 1×) peers Chittibabu Vatte

Countries citing papers authored by Emilsé Bermejo

Since Specialization
Citations

This map shows the geographic impact of Emilsé Bermejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilsé Bermejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilsé Bermejo more than expected).

Fields of papers citing papers by Emilsé Bermejo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilsé Bermejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilsé Bermejo. The network helps show where Emilsé Bermejo may publish in the future.

Co-authorship network of co-authors of Emilsé Bermejo

This figure shows the co-authorship network connecting the top 25 collaborators of Emilsé Bermejo. A scholar is included among the top collaborators of Emilsé Bermejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilsé Bermejo. Emilsé Bermejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagliardi, Juan, et al.. (2026). Evaluación de los niveles plasmáticos de células progenitoras en pacientes con enfermedad coronaria crónica. Revista Argentina de Cardiología. 75(6). 429–435.
2.
Bermejo, Emilsé, David S. Paul, Paquita Nurden, et al.. (2017). Marked bleeding diathesis in patients with platelet dysfunction due to a novel mutation in RASGRP2, encoding CalDAG-GEFI (p.Gly305Asp). Platelets. 29(1). 84–86. 14 indexed citations
3.
Woods, Adriana Inés, A Blanco, Ana Catalina Kempfer, et al.. (2016). Factor von Willebrand y Enfermedad de von Willebrand: nuevos enfoques diagnósticos. Acta bioquímica clínica latinoamericana. 50(2). 273–289.
4.
Gagliardi, Juan, Osvaldo Masoli, Verónica Miksztowicz, et al.. (2015). Relationship between endothelial progenitor cells and vascular endothelial growth factor and its variation with exercise. Thrombosis Research. 137. 92–96. 7 indexed citations
5.
Bermejo, Emilsé, Robert Combrié, Daniel W. McVicar, et al.. (2008). Phenotypic heterogeneity in the gray platelet syndrome extends to the expression of TREM family member, TLT-1. Thrombosis and Haemostasis. 100(7). 45–51. 13 indexed citations
6.
Bermejo, Emilsé, et al.. (2005). Effect of nitroxyl on human platelets function. Thrombosis and Haemostasis. 94(9). 578–584. 49 indexed citations
7.
Bermejo, Emilsé, et al.. (2004). Assessment of platelet activation in myeloproliferative disorders with complementary techniques. Blood Coagulation & Fibrinolysis. 15(3). 235–240. 11 indexed citations
8.
Clofent‐Sanchez, Gisèle, Catherine Jaïs, Emilsé Bermejo, et al.. (2004). Delayed immunologic thrombocytopenia induced by abciximab. Thrombosis and Haemostasis. 92(10). 820–828. 11 indexed citations
9.
Chudzinski-Tavassi, A.M., Emilsé Bermejo, Ruth E. Rosenstein, et al.. (2003). Nitridergic Platelet Pathway Activation by Hementerin, a Metalloprotease from the Leech Haementeria depressa. Biological Chemistry. 384(9). 1333–9. 9 indexed citations
10.
Casais, Patricia, Susana Meschengieser, Analía Sánchez‐Luceros, Emilsé Bermejo, & M.A. Lazzari. (2002). Effect of Low-Dose Aspirin on the International Normalized Ratio Variability in Patients with Mechanical Heart Valve Prostheses. Pathophysiology of Haemostasis and Thrombosis. 32(4). 155–157. 7 indexed citations
11.
Dran, Graciela, Gabriela Fernández, Carolina Rubel, et al.. (2002). Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome. Kidney International. 62(4). 1338–1348. 26 indexed citations
12.
Dran, Graciela, Gabriela Fernández, Carolina Rubel, et al.. (2002). Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome. Kidney International. 62(4). 1338–1348. 2 indexed citations
13.
Meschengieser, Susana, et al.. (2001). Recurrent haemoperitoneum in a mild von Willebrand's disease combined with a storage pool deficit. Blood Coagulation & Fibrinolysis. 12(3). 207–209. 13 indexed citations
14.
Lozano, Marı́a Luisa, José Rivera, Emilsé Bermejo, et al.. (2000). In vitro analysis of platelet concentrates stored in the presence of modulators of 3′,5′ adenosine monophosphate, and organic anions. Transfusion Science. 22(1-2). 3–11. 6 indexed citations
15.
Fondevila, Carlos, Susana Meschengieser, Emilsé Bermejo, & M.A. Lazzari. (1997). Persistence of low platelet adhesiveness in von Willebrand disease during pregnancy. Platelets. 8(2-3). 155–157. 2 indexed citations
16.
Maugeri, Norma, et al.. (1991). Effect of histamine on human lymphocyte aggregation. Thrombosis Research. 61(2). 149–154. 2 indexed citations
17.
Maugeri, Norma, Emilsé Bermejo, & M.A. Lazzari. (1990). Adenosine triphosphate released from human mononuclear cells. Thrombosis Research. 59(5). 887–890. 3 indexed citations
18.
Bermejo, Emilsé, Ana Catalina Kempfer, Mirta Schattner, et al.. (1989). Partial purification of a bioactive substance(s) from human veins independent of prostacyclin production. Thrombosis Research. 55(3). 385–388.
19.
Maugeri, Norma, Emilsé Bermejo, A. Faletti, et al.. (1989). The influence of sex and different segments of thoracic aorta on bioactive aortic substance (BAS) and prostacyclin (PGI2) synthesis. Thrombosis Research. 56(1). 19–27. 3 indexed citations
20.
Kempfer, Ana Catalina, Norma Maugeri, C. Farías, et al.. (1988). Purification and partial characterization of a bioactive substance from rat's vessel wall independent of prostacyclin production. Thrombosis Research. 52(2). 127–135. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026